China Southern Airlines (1055.HK): Lifting by the progress of vaccine

China Southern Airlines (1055.HK) is lifted by the progress of the developing the vaccine of coronavirus

Uptrend 2

China Southern Airlines (1055.HK) is lifted by the progress of the developing the vaccine of coronavirus. The vaccine developers, such as Pfizer, Biontech and Moderna, said the effectiveness of vaccines can achieve more than 90%. Investors are expecting that the worst situation for airlines is going to be over.

Recently, the company is updated from "equalweight" to "overweight" at Morgan Stanley. In addition, the target price is also raised from HK$2.97 to HK$4.19.

From a technical point of view, the stock broke above the consolidation zone between HK$4.00 and HK$4.45 on the daily. Currently, it is trading above both rising 20-day and 50-day moving averages. Bullish readers could set the support level at HK$4.45, while resistance level would be located at HK$5.33 and HK$5.65.


Source: GAIN Capital, TradingView

More from Equities

Join our live webinars for the latest analysis and trading ideas. Register now

GAIN Capital UK Limited (trading as “City Index”) is an execution-only service provider. This material, whether or not it states any opinions, is for general information purposes only and it does not take into account your personal circumstances or objectives. This material has been prepared using the thoughts and opinions of the author and these may change. However, City Index does not plan to provide further updates to any material once published and it is not under any obligation to keep this material up to date. This material is short term in nature and may only relate to facts and circumstances existing at a specific time or day. Nothing in this material is (or should be considered to be) financial, investment, legal, tax or other advice and no reliance should be placed on it.

No opinion given in this material constitutes a recommendation by City Index or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person. The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although City Index is not specifically prevented from dealing before providing this material, City Index does not seek to take advantage of the material prior to its dissemination. This material is not intended for distribution to, or use by, any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.

For further details see our full non-independent research disclaimer and quarterly summary.